456 related articles for article (PubMed ID: 15792176)
1. Seventeen-year clinical results of 1,037 Mitroflow pericardial heart valve prostheses in the aortic position.
Yankah CA; Schubel J; Buz S; Siniawski H; Hetzer R
J Heart Valve Dis; 2005 Mar; 14(2):172-9; discussion 179-80. PubMed ID: 15792176
[TBL] [Abstract][Full Text] [Related]
2. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients.
McClure RS; Narayanasamy N; Wiegerinck E; Lipsitz S; Maloney A; Byrne JG; Aranki SF; Couper GS; Cohn LH
Ann Thorac Surg; 2010 May; 89(5):1410-6. PubMed ID: 20417753
[TBL] [Abstract][Full Text] [Related]
3. CarboMedics Mitroflow pericardial aortic bioprosthesis - performance in patients aged 60 years and older after 15 years.
Benhameid O; Jamieson WR; Castella M; Carrier M; Pomar JL; Germann E; Pellerin M; Brownlee RT
Thorac Cardiovasc Surg; 2008 Jun; 56(4):195-9. PubMed ID: 18481236
[TBL] [Abstract][Full Text] [Related]
4. Medtronic mosaic porcine bioprosthesis: investigational center experience to six years.
Jamieson WR; Fradet GJ; MacNab JS; Burr LH; Stanford EA; Janusz MT; Abel JG; Germann E; Cheung A
J Heart Valve Dis; 2005 Jan; 14(1):54-63. PubMed ID: 15700437
[TBL] [Abstract][Full Text] [Related]
5. Mitroflow pericardial valve prosthesis in the aortic position: an analysis of long-term outcome and prognostic factors.
Minami K; Boethig D; Mirow N; Kleikamp G; Koertke H; Godehardt E; Koerfer R
J Heart Valve Dis; 2000 Jan; 9(1):112-22. PubMed ID: 10678383
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous aortic and mitral valve replacement: predictors of adverse outcome.
Kuwaki K; Tsukamoto M; Komatsu K; Morishita K; Sakata J; Abe T
J Heart Valve Dis; 2003 Mar; 12(2):169-76. PubMed ID: 12701788
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of the MitroFlow pericardial bioprosthesis in the elderly after aortic valve replacement.
Sjögren J; Gudbjartsson T; Thulin LI
J Heart Valve Dis; 2006 Mar; 15(2):197-202. PubMed ID: 16607900
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular mass regression after aortic valve replacement with the new Mitroflow 12A pericardial bioprosthesis.
García-Bengochea J; Sierra J; González-Juanatey JR; Rubio J; Vega M; Fernández AL; Sánchez D
J Heart Valve Dis; 2006 May; 15(3):446-51; discussion 451-2. PubMed ID: 16784087
[TBL] [Abstract][Full Text] [Related]
9. Lack of durability of the Mitroflow valve does not affect survival.
Houel R; Le Besnerais P; Soustelle C; Kirsch M; Hillion ML; Loisance D
J Heart Valve Dis; 1999 Jul; 8(4):368-74; discussion 374-5. PubMed ID: 10461235
[TBL] [Abstract][Full Text] [Related]
10. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years.
Yankah CA; Pasic M; Musci M; Stein J; Detschades C; Siniawski H; Hetzer R
J Thorac Cardiovasc Surg; 2008 Sep; 136(3):688-96. PubMed ID: 18805273
[TBL] [Abstract][Full Text] [Related]
11. Long-term durability and patient functional status of the Carpentier-Edwards Perimount pericardial bioprosthesis in the aortic position.
Frater RW; Furlong P; Cosgrove DM; Okies JE; Colburn LQ; Katz AS; Lowe NL; Ryba EA
J Heart Valve Dis; 1998 Jan; 7(1):48-53. PubMed ID: 9502139
[TBL] [Abstract][Full Text] [Related]
12. Biological versus mechanical aortic prosthesis? A nineteen-year comparison in a propensity-matched population.
Bottio T; Rizzoli G; Caprili L; Testolin L; Thiene G; Gerosa G
J Heart Valve Dis; 2005 Jul; 14(4):493-500. PubMed ID: 16116876
[TBL] [Abstract][Full Text] [Related]
13. Mitroflow aortic pericardial bioprosthesis--clinical performance.
Jamieson WR; Koerfer R; Yankah CA; Zittermann A; Hayden RI; Ling H; Hetzer R; Dolman WB
Eur J Cardiothorac Surg; 2009 Nov; 36(5):818-24. PubMed ID: 19700338
[TBL] [Abstract][Full Text] [Related]
14. Twelve-year experience with the 19 mm Carpentier-Edwards pericardial aortic valve.
Nakajima H; Aupart MR; Neville PH; Sirinelli AL; Meurisse YA; Marchand MA
J Heart Valve Dis; 1998 Sep; 7(5):534-9. PubMed ID: 9793853
[TBL] [Abstract][Full Text] [Related]
15. Mitroflow synergy prostheses for aortic valve replacement: 19 years experience with 1,516 patients.
Minami K; Zittermann A; Schulte-Eistrup S; Koertke H; Körfer R
Ann Thorac Surg; 2005 Nov; 80(5):1699-705. PubMed ID: 16242441
[TBL] [Abstract][Full Text] [Related]
16. CarboMedics mechanical prosthesis: performance at eight years.
Jamieson WR; Fradet GJ; Miyagishima RT; Henderson C; Brownlee RT; Zhang J; Germann E
J Heart Valve Dis; 2000 Sep; 9(5):678-87. PubMed ID: 11041184
[TBL] [Abstract][Full Text] [Related]
17. Carpentier-Edwards supra-annular aortic porcine bioprosthesis: clinical performance over 20 years.
Jamieson WR; Burr LH; Miyagishima RT; Germann E; Macnab JS; Stanford E; Chan F; Janusz MT; Ling H
J Thorac Cardiovasc Surg; 2005 Oct; 130(4):994-1000. PubMed ID: 16214510
[TBL] [Abstract][Full Text] [Related]
18. Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years' experience in 130 patients.
D'Onofrio A; Auriemma S; Magagna P; Favaro A; Cannarella A; Piccin C; Bilotta M; Abbiate N; Lamascese N; Fabbri A
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):491-5. PubMed ID: 17662795
[TBL] [Abstract][Full Text] [Related]
19. The Mitroflow pericardial valve: clinical performance to 10 years.
Mazzucotelli JP; Bertrand PC; Loisance DY
J Heart Valve Dis; 1995 Jul; 4(4):407-13. PubMed ID: 7582152
[TBL] [Abstract][Full Text] [Related]
20. The Stentless Cryo-Life O'Brien porcine aortic valve at 10 years.
Hvass U; Baron F; Elsebaey A; Nguyen D; Flecher E
J Heart Valve Dis; 2004 Nov; 13(6):977-83; discussion 983. PubMed ID: 15597593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
